Fulgent Genetics (FLGT) Tax Provisions (2016 - 2026)

Fulgent Genetics has disclosed Tax Provisions across 11 years of filings, most recently posting -$700000.0 for Q1 2026.

• Tax Provisions for Q1 2026 came in at -$700000.0, down 450.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$8.2 million (down 7.52% YoY), and the FY2025 annual result was -$7.3 million, up 10.77% from the prior year.
• Tax Provisions came in at -$700000.0 for Q1 2026 at Fulgent Genetics, up from -$4.5 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $48.4 million in Q1 2022 to a low of -$22.3 million in Q4 2023.
• The 5-year median for Tax Provisions is -$1.9 million (2024), against an average of $920941.2.
• Across the five-year window, Tax Provisions jumped 4803.38% in 2023 and plunged 450.0% in 2026, its largest moves.
• Fulgent Genetics' Tax Provisions stood at -$9.4 million in 2022, then slumped by 137.72% to -$22.3 million in 2023, then jumped by 91.69% to -$1.9 million in 2024, then plunged by 142.05% to -$4.5 million in 2025, then soared by 84.41% to -$700000.0 in 2026.
• The last three Tax Provisions figures came in at -$700000.0 (Q1 2026), -$4.5 million (Q4 2025), and -$700000.0 (Q3 2025), per Business Quant data.